Low Seroprevalence among Undetected COVID-19 Cases, Faroe Islands, November 2020
We conducted a second nationwide severe acute respiratory syndrome coronavirus 2 seroprevalence study in the Faroe Islands during November 2020. We found crude seroprevalence was 0.3% and prevalence was 0.4% after adjusting for test sensitivity and specificity. This low seroprevalence supports the p...
Published in: | Emerging Infectious Diseases |
---|---|
Main Authors: | , , , , , , , , , |
Format: | Article in Journal/Newspaper |
Language: | English |
Published: |
Centers for Disease Control and Prevention
2022
|
Subjects: | |
Online Access: | https://doi.org/10.3201/eid2801.210917 https://doaj.org/article/731c5a04305b4abd835f27d9c4a5b7cd |
Summary: | We conducted a second nationwide severe acute respiratory syndrome coronavirus 2 seroprevalence study in the Faroe Islands during November 2020. We found crude seroprevalence was 0.3% and prevalence was 0.4% after adjusting for test sensitivity and specificity. This low seroprevalence supports the prevention strategies used in the Faroe Islands. |
---|